Source: PR Newswire

Press Release: Fluxion Biosciences, Inc. : Fluxion Biosciences Introduces a Complete System for Lead-to-Answer Screening in Ion Channel Assays

ALAMEDA, Calif., Sept. 20, 2022 /PRNewswire/ -- Fluxion Biosciences, a global leader in automated patch clamp systems for ion channel drug discovery, today announced the release of an integrated and affordable solution for simplifying automated ion channel assays. Ion channels are the...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Jeff Jensen's photo - CEO of Fluxion

CEO

Jeff Jensen

CEO Approval Rating

88/100

Read more